Peptide Fractionation & 2D LC Trapping
Optimize documents a tandem trapping workflow for peptide fractionation and downstream LC analysis that combines two distinct application-specific trapping functions.
The documented sequence is:
SCX trapping/fractionation -> controlled peptide release -> peptide concentration/desalting -> downstream elution and LC analysis
This is one Optimize-documented tandem workflow. It should not be treated as a universal definition of two-dimensional LC or as a general description of every 2D LC method.
This page identifies the supported application path, the two application-specific chemistry identities involved, and the confirmed product-family route. Exact cartridge sizing, holder hardware, connections, fittings, and part number are selected later.
The Documented Tandem Workflow
The workflow uses two distinct trapping stages with different functions.
The first stage uses the application-specific SCX (Strong Cation Exchange) Trap for the documented SCX trapping and fractionation step.
After controlled peptide release from that stage, the workflow uses the application-specific Peptide Concentration & Desalting Trap for peptide concentration and desalting before downstream elution and LC analysis.
At a high level, the supported sequence remains:
SCX trapping/fractionation -> controlled peptide release -> peptide concentration/desalting -> downstream elution and LC analysis
The workflow should be interpreted as a connected application path. The presence of a related chemistry name in another product family does not independently establish support for the complete workflow.
Preserve the Application-Specific Chemistry Identities
The two chemistry names in this documented workflow are application-specific identities:
SCX (Strong Cation Exchange) Trap
SCX (Strong Cation Exchange) Trap is the application-specific identity used for the documented first stage of this workflow.
It must remain distinct from generic SCX. The availability of a generic SCX phase does not, by itself, establish that the same chemistry relationship or complete 2D application is supported.
For additional exact-name chemistry context, see Trap Chemistry Reference.
Peptide Concentration & Desalting Trap
Peptide Concentration & Desalting Trap is the application-specific identity used for the documented peptide concentration-and-desalting stage.
It should not be treated as interchangeable with generic Peptide, Peptides ES-C18, C8, C18, or another phase based solely on related terminology or historical retention comparisons.
For concentration and desalting applications outside this documented tandem workflow, see Sample Concentration & Desalting.
Confirmed Product-Family Route
For the complete documented peptide-fractionation and tandem 2D trapping application, OPTI-TRAP is the confirmed product-family route.
The application-level customer journey is:
peptide fractionation / tandem 2D objective -> application-specific SCX and peptide concentration/desalting chemistry -> OPTI-TRAP family route -> check system viability -> choose the exact configuration
Reaching the supported family route does not require the customer to first choose:
- bed volume;
- cartridge dimensions;
- holder hardware;
- fittings;
- connections;
- exact SKU.
Those decisions belong to the later configuration stage.
For product selection after reaching the supported family route, continue to OPTI-TRAP Cartridges.
Check System Viability
After the application and product-family route are established, confirm that the intended method and LC system are suitable for the supported family.
Documented system constraints such as operating pressure, flow requirements, or connection requirements may determine whether the supported route is viable for a particular installation or method.
A system constraint does not independently establish another trap family as an application-equivalent substitute.
If an established system constraint makes the documented OPTI-TRAP route unsuitable, contact Optimize Technologies for technical review rather than automatically switching to another trap family.
Choose the Exact Configuration
Once the application path and supported product family have been established, move to the configuration stage.
The later configuration step may require selection of:
- bed volume;
- cartridge dimensions;
- holder hardware;
- fittings;
- connections;
- exact product or part number.
Those configuration decisions should not be used as prerequisites for determining whether the documented peptide-fractionation / tandem 2D application path applies.
For documented cartridge-to-holder physical fit, use Trap Compatibility & Holder Reference. Physical fit should not be inferred from product names, dimensions, thread descriptions, branding, appearance, shared architecture, or hardware similarity.
When Technical Review Is the Right Next Step
Contact Optimize Technologies when:
- an established system constraint makes the supported OPTI-TRAP route unsuitable;
- the required chemistry relationship is unclear;
- the intended workflow differs materially from the documented tandem application;
- exact configuration cannot be established from approved product information;
- a required cartridge-to-holder physical-fit relationship is not explicitly documented.
An unsupported chemistry or hardware relationship should not be used to create an automatic alternative family route.
Related Trapping Resources
For general trapping principles and terminology, see Trapping Fundamentals / Technical Reference.
For exact chemistry identities and distinctions between application-specific and generic phase names, see Trap Chemistry Reference.
For concentration or desalting outside this documented tandem workflow, see Sample Concentration & Desalting.
For documented cartridge-to-holder physical-fit evidence, see Trap Compatibility & Holder Reference.
For product selection after reaching the confirmed OPTI-TRAP family route, continue to OPTI-TRAP Cartridges.
For unresolved method, system, chemistry, configuration, or compatibility questions, contact Optimize Technologies.